Joint venture China, subsidiary (WFOE) or hybrid?
By Frank-Christan Raffel Frank-Christian Raffel has been analyzing and shaping the strategy and corporate form of European companies in China and Southeast Asia since 1997, when he conducted a broad-based study in cooperation with the Hong Kong and Shanghai Chambers of Commerce. It is remarkable how often we hear the question even today, in the […]
IDS – White Paper Dental Market CHINA: Opportunities with new strategic approaches in a challenging environment
By Frank-Christian Raffel The Chinese dental market continues to be the fastest growing and strategically most important market in the world, with particular challenges for international companies. Ahead of IDS in Cologne in February 2025, MRL Advisors published a white paper incl. results of the survey of dental product suppliers from Germany, Austria and Switzerland […]
AI-powered medical imaging in the Chinese healthcare market: revolutionizing radiology
By Frank-Christian Raffel The healthcare sector in China is in the midst of a profound transformation, driven by the use of artificial intelligence (AI) in medical imaging. Through massive investment and rapid technological advancement, AI is transforming radiology while providing new opportunities to improve diagnostic accuracy, optimize workflows and expand access to healthcare services. Fig. […]
Selling companies to China and the USA – Still possible from a regulatory perspective?
By MRL Advisors Research Germany, as the EU’s largest economy, has revised and tightened its screening mechanisms for foreign direct investment (FDI) in recent years. Investments in key sectors such as AI, semiconductors, quantum computing and biotechnology were scrutinized with increased attention, particularly in response to global trends towards technological sovereignty. Does this mean the […]